Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H4 | Q96RI1 | 10/20 | 0.52 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.33 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.33 |
| ▸ | NPBWR1 | P48145 | 2/20 | 0.33 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.33 |
| ▸ | MRGPRX4 | Q96LA9 | 2/20 | 0.33 |
| ▸ | GCGR | P47871 | 1/20 | 0.33 |
| ▸ | CYP26A1 | O43174 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4036782 | 0.92 | NR1H4 (0.61) | NR1H4MRGPRX4 | |
| SCHEMBL2772298 | 0.89 | NR1H4 (0.54) | NR1H4NR1H2NR1H3NPBWR1MCHR1 | |
| SCHEMBL4042349 | 0.87 | NR1H4 (0.52) | NR1H4NR1H2NR1H3NPBWR1MCHR1 | |
| SCHEMBL2770907 | 0.84 | NR1H4 (0.52) | NR1H4NR1H2NR1H3NPBWR1MCHR1 | |
| SCHEMBL2772976 | 0.82 | NR1H4 (0.63) | NR1H4MRGPRX4 | |
| SCHEMBL2770222 | 0.80 | NR1H4 (0.56) | NR1H4NPBWR1MCHR1MRGPRX4KMT2A | |
| SCHEMBL2771757 | 0.80 | NR1H4 (0.65) | NR1H4MRGPRX4 | |
| SCHEMBL2771111 | 0.79 | NR1H4 (0.58) | NR1H4NPBWR1MCHR1MRGPRX4KMT2A | |
| SCHEMBL2772411 | 0.79 | NR1H4 (0.61) | NR1H4MRGPRX4 | |
| SCHEMBL2770911 | 0.79 | NR1H4 (0.52) | NR1H4NR1H2NR1H3NPBWR1MCHR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2029547-A1 | FXR AGONISTS | ELI LILLY AND COMPANY (US) | 2009-03-04 | — | — | EP | disclosed |
| WO-2007140183-A1 | FXR AGONISTS | ELI LILLY AND COMPANY (US) | 2007-12-06 | — | — | WO | disclosed |